Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic Acid + Phototherapy for Neonatal Indirect Hyperbilirubinemia
NCT07867366Completed
- Start
- Feb 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of ursodeoxycholic acid in hyperbilirubinemia (2 arms). Primary endpoint: Mean serum bilirubin level at 48 hours. Started Feb 2026; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
hyperbilirubinemia
Beyond the preview
Go deeper on NCT07867366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07867366.